Limb arteritis in Horton disease: A case series of five patients;Atteinte des artères des membres et maladie de Horton : à propos de cinq cas

Revue de Medecine Interne

Volumn 30, Issue 12, 2009, Pages 1004-1010

  Benjilali, L ^a   Tazi Mezalek, Z ^a   Raffali, J ^a   El Imadi, H ^a   Harmouche, H ^a   Adnaoui, M ^a   Bensaid, Y ^a   Aouni, M ^a   Maaouni, A ^a  

^a IBN SINA HOSPITAL   (Morocco)

Author keywords

Limb arteriopathy; Temporal arteritis

Indexed keywords

ACUTE PHASE PROTEIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; C REACTIVE PROTEIN; HEPARIN; ILOPROST; METHYLPREDNISOLONE;

ADULT; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL BIOPSY; CLINICAL ARTICLE; FEMALE; GIANT CELL ARTERITIS; HUMAN; LIMB AMPUTATION; LIMB ISCHEMIA; TEMPORAL ARTERITIS; TEMPORAL ARTERY;

AGED; AMPUTATION; ANTICOAGULANTS; ARTERITIS; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; FEMORAL ARTERY; GIANT CELL ARTERITIS; GLUCOCORTICOIDS; HUMANS; LEG; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 71749093248     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.05.004     Document Type: Article

References (43)

1. Barrier J.H., Chevalet P., and Liozon F. Maladie de Horton. In: Kahn M.-F., Peiltier A.P., Meyer O., and Piette J.C. (Eds). Maladies et syndromes systémiques (2000), Édition Médecine Sciences Flammarion, Paris 653-684
2. Liozon E., and Ly K. Giant cell arteritis. Rev Prat 58 (2008) 513-521
3. Jennings G.H. Arteritis of temporal vessels. Lancet I (1938) 424-428
4. Lorthioir A., Marie I., Tetart F., Bernet J., and Lévesque H. Artérite au cours de la maladie de Horton : à propos de deux observations et revue de la littérature. Rev Med Interne 29 (2008) 1007-1012
5. Piette A.M., and Bletry O. Atteinte des gros troncs artériels dans la maladie de Horton. Rev Prat 49 (1999) 609-612
6. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33 (1990) 1122-1128
7. Garcia-Martinez A., Hernandez-Rodriguez J., Arguis P., Paredes P., Segarra M., Lozano E., et al. Development of aortic aneurysm/dilatation during the follow up of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 59 (2008) 422-430
8. Agard C., Barrier J.H., Dupas B., Ponge T., Mahr A., Fradet G., et al. Aortic involvement in recent onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 59 (2008) 670-676
9. Evans J.M., O'Fallon W.M., and Hunder G.C. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 122 (1995) 502-507
10. Garcia-Porrua C., Pego-Reigosa R., Pifleiro A., Armesto V., and Gonzalez-Gay M. Supraclavicular pulsatile mass as presenting sign of brachiocephalic trunk aneurysm in the long-term follow-up of giant cell arteritis. Arthritis Rheum 53 (2005) 475-476
11. Hamrin B., Jonsson N., and Landberg T. Involvement of large vessels in polymyalgia arteritica. Lancet I (1965) 1193-1196
12. Lie J.T. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 24 (1995) 422-431
13. Le Hello C., Lévesque H., Jeanton M., Cailleux N., Galateau F., Peillon C., et al. Lower limb giant cell arteritis and temporal arteritis: follow up of 8 cases. J Rheumatol 28 (2001) 1407-1412
14. Tazi Z., Cacoub P., Cheysson D., Godeau P., and Piette J.C. Maladie de Horton démasquée par une artériopathie inflammatoire spécifique des membres inférieurs. Rev Med Interne 18 (1997) 638-641
15. Ferrandiz D., Joguet R., and Yvin J.L. Ischémie subaiguë du membre supérieur survenant à la phase initiale du traitement corticoïde d'une maladie de Horton. Rev Med Interne 20 (1999) 86-87
16. Bacourt F. Artériopathies chroniques oblitérantes athéromateuses des membres inférieurs. In: Godeau P., Herson S., and Piette J.C. (Eds). Traité de médecine Tome 1 (2004), Édition Médecine Sciences Flammarion, Paris 703-705
17. Tato F., and Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 44 (2006) 176-182
18. Schmidt W.A., and Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 17 (2005) 9-15
19. Karassa F.B., Matsagas M.I., Schmidt W.A., and Ionnidis J.P.A. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 142 (2005) 359-369
20. Schmidt W.A., Seifert A., Gromnica-Ihle E., Krause A., and Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology 47 (2008) 96-101
21. Barrier J.H., and Généreau T. Maladie de Horton et pseudopolyarthrite rhizomélique. In: Godeau P., Herson S., and Piette J.C. (Eds). Traité de médecine Tome 1 (2004), Édition Médecine Sciences Flammarion, Paris 192-196
22. Hervé F., Choussy V., Janvresse A., Cailleux N., Levesque H., and Marie I. Aortite inflammatoire et maladie de Horton. À propos du suivi évolutif scannographique prospectif d'une série de 11 patients. Rev Med Interne 27 (2006) 196-202
23. Agard C., Hamidou M.A., Said L., Ponge T., Connault J., Chevalet P., et al. Dépistage de l'atteinte aortique abdominale par l'échographie-doppler au diagnostic de maladie de Horton. Étude prospective de 30 patients. Rev Med Interne 28 (2007) 363-370
24. Narvaez J., Naevaez J.A., Nolla J.M., Sirvent E., Reina D., and Valverde J. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology 44 (2005) 479-483
25. Bley T.A., Markl M., Schelp M., Uhl M., Frydrychowicz A., Vaith P., et al. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment. Rheumatology 47 (2008) 65-67
26. Bley T.A., Warnatz K., Wieben O., Uhl M., Scholz C., Vaith P., et al. High-resolution MRI in giant cell arteritis with mutiple inflammatory stenoses in both calves. Rheumatology 44 (2005) 954-955
27. Belhocine T., Kaye O., Delanaye P., Corman V., Baghaie M., Deprez M., et al. Maladie de Horton et atteintes artérielles extra-temporales : utilité de la tomographie par émission de positrons au 18FDG. À propos de trois observations et d'une revue de la littérature. Rev Med Interne 23 (2002) 584-591
28. Raynaud F.R., Huglo D., and Steinling M. La tomographie d'émission de positrons en médecine interne : applications actuelles et perspectives d'avenir. Rev Med Interne 27 (2006) 932-945
29. Kwon C.M., Hong Y.H., Chun K.A., Cho I.H., Kim M.J., Shin D.G., et al. A case of silent giant cell arteritis involving the entire aorta, carotid artery and brachial artery screened by integrated PET/CT. Clin Rheumatol 26 (2007) 1959-1962
30. Brodmann M., Lipp R.W., Passath A., Seinost G., Pabst E., and Pilger E. The role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology 43 (2004) 241-242
31. Blockmans D., Stroobants S., Macs A., and Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 26 (2000) 314-319
32. Ray J.G., Ramdani M.M., and Geerts W.H. Giant cell arteritis and cardiovascular disease in older adults. Heart 91 (2005) 324-328
33. Agard C., and Barrier J.H. La maladie de Horton simple : modalités thérapeutiques. Presse Med 33 (2004) 41-50
34. Agard C., and Barrier J.H. La maladie de Horton compliquée : modalités thérapeutiques. Presse Med 33 (2004) 51-59
35. Kaiser M., Weyand C.M., Bjornsson J., and Goronzy J.J. Platelet derived growth factor, intimal hyperplasia and ischemic complications in giant cell arteritis. Arthritis Rheum 41 (1998) 623-633
36. Duhaut P. Maladie de Horton et pseudopolyarthrite rhizomélique : nouveautés thérapeutiques ? Évolution et pronostic. Rev Med Interne 29 Suppl 3 (2008) s281-s285
37. Jouquan J., Mottier D., Cleuziou A., Pennec Y., Baccino E., Bergeret G., et al. Accidents vasculaires cérébraux précoces au cours des maladies de Horton traitées : responsabilité du traitement corticoïde ?. Ann Med Interne (Paris) 135 (1984) 526-529
38. Paccalin M., Amoura Z., Roblot P., Godeau P., Becq-Giraudon B., and Piette J.C. Accidents vasculaires encéphaliques précoces après instauration d'une corticothérapie au cours de la maladie de Horton. Rev Med Interne 21 (2000) 550-554
39. Wadman B., and Werner I. Thromboembolic complications during corticoid treatment of temporal arteritis. Lancet I (1972) 907
40. Lee M.S., Smith S.D., Galor A., and Hoffman G.S. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 54 (2006) 3306-3309
41. Weyand C.M., Kaiser M., Yang H., Younge B., and Goronzy J.J. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 46 (2002) 457-466
42. Nesher G., Berkun Y., Mates M., Baras M., Rubinow A., and Sonnenblik M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50 (2004) 1332
43. Both M., Aries P.M., Muller-Hullsbeck S., Jahnke T., Schafer P.J., Gross W.L., et al. Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis 65 (2006) 1124-1130